MSH|^~\&|ELAB^1.3.6.1.4.1.4329.22.6.5.1.10^ISO|AH^2.16.840.1.113883.3.72.5.30.2^ISO| LAB^1.3.6.1.4.1.4329.22.6.5.1.1^ISO|AH^2.16.840.1.113883.3.72.5.30.2^ISO|20140204063500-0500||ORU^R01^ORU_R01|140350000000497|P|2.5.1|||AL|NE|||||LRI_GU_RU_Profile^HL7^2.16.840.1.113883.9.17^ISO~LRI_TO_Component^HL7^2.16.840.1.113883.9.22^ISO~LRI_NB_Component^HL7^2.16.840.1.113883.9.24^ISO
SFT|SIEMENS^L^^^^AH&1.3.6.1.4.1.4329.22.6.5.1.1&ISO^XX|27.1.0|NOVIUS Lab|2710||201308291907-0500
PID|1||60080010^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^PN^AH&2.16.840.1.113883.3.72.5.30.2&ISO~70080010^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^MR^AH&2.16.840.1.113883.3.72.5.30.2&ISO||JONES^WILLIAM^A^JR^^^L^^^^^^^||19610615|M||W^WHITE^L^2106-3^White^HL70005||||||||60080010^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^AN^AH&2.16.840.1.113883.3.72.5.30.2&ISO||||||||||||N|||201402031442-0500|AH^2.16.840.1.113883.3.72.5.30.2^ISO
PV1|1|I|^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^AH^^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO||||366^RADON^NICHOLAS^M^JR^^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^Dr||366^RADON^NICHOLAS^M^JR^^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^Dr||||||||366^RADON^NICHOLAS^M^JR^^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^Dr|AIP||P|||||||||||||||||||AH|||||201310150800
ORC|RE|SampleID^LAB^1.3.6.1.4.1.4329.22.6.5.1.1^ISO|3471_152^ELAB^1.3.6.1.4.1.4329.22.6.5.1.10^ISO||CM||||201402030730|SUPERV^^^^^^^USER||366^RADON^NICHOLAS^M^JR^DR^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^Dr||^PRN^PH^^^407^2341212^^^^^407-234-1212|201402030730||AH^A HEALTH CAREFACILITY^L||||AH^L^^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^XX|6029 SOMERSET DR^^PHILADELPHIA^PA^19101^USA^B|^WPN^PH^^01^610^2196300^1817|555 Orange Ave^^Oveido^FL^32765^USA^B
OBR|1|SampleID^LAB^1.3.6.1.4.1.4329.22.6.5.1.1^ISO|3471_152^ELAB^1.3.6.1.4.1.4329.22.6.5.1.10^ISO|LIP1996^Lipid Panel ^L^24331-1^Lipid 1996 panel in Serum or Plasma^LN^27.1.0^2.40^Lipid 1996 panel in Serum or Plasma|||201402030800-0500|201402030800-0500||wjo^William Ormerod^^^^^^USER|L||LIP^LIPEMIC^L^3744001^hyperlipoproteinemia^SCT^27.1^07/31/2012^hyperlipoproteinemia|||366^RADON^NICHOLAS^M^JR^DR^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^Dr|^PRN^PH^^^407^2341212^^^^^407-234-1212|||1||201402040635-0500|||F|||393^HAMLIN^PAFFORD^M^SR.^DR.^^^AH&2.16.840.1.113883.3.72.5.30.2&ISO^L^^^DN^AH&2.16.840.1.113883.3.72.5.30.2&ISO^^^^^^^||||wjo   &Ormerod&William&John&JR&DR&PHD&&LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO||||201402030800|||||||||||||BCC^Blind Copies Requested^L^BCC^Blind Copy^HL70507^27.1.0^2.5.1^Blind Copy 
TQ1|1|1|||||201402030800-0500|201402030800-0500|ROUT^ROUT^L
OBX|1|NM|CHOL^CHOL^L^2093-3^Cholesterol [Mass/volume] in Serum or Plasma^LN^27.1.0^2.40^Cholesterol [Mass/volume] in Serum or Plasma||196|MGDL^mg/dL^L^mg/dL^milligrams per deciliter^UCUM^27.1.0^^mg/dL|Recommended: <200; Moderate Risk: 200-239 ; High Risk: >240|N|||F||040.00.029.0|201402101618-0500||wjo^William Ormerod^^^^^^USER^LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO^^^^RI||DIM1A|201402101621-0500||||CEN^L^^^^Century Hospital&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|2|NM|TRIG^Trig^L^2571-8^Triglyceride [Mass/volume] in Serum or Plasma^LN^27.1.0^2.40^Triglyceride [Mass/volume] in Serum or Plasma||100|MGDL^mg/dL^L^mg/dL^milligrams per deciliter^UCUM^27.1.0^^mg/dL|40 to 160|N|||F||040.00.031.0|201402101618-0500||wjo^William Ormerod^^^^^^USER^LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO^^^^RI||DIM1A|201402101621-0500||||CEN^L^^^^Century Hospital&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|3|NM|HDL^HDL^L^2085-9^Cholesterol in HDL [Mass/volume] in Serum or Plasma^LN^27.1.0^2.40^Cholesterol in HDL [Mass/volume] in Serum or Plasma||60|MGDL^mg/dL^L^mg/dL^milligrams per deciliter^UCUM^27.1.0^^mg/dL|29 to 72|N|||F||040.00.041.0|201402101618-0500||wjo^WilliamOrmerod^^^^^^USER^LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO^^^^RI||DIM1A|201402101621-0500||||CEN^L^^^^Century Hospital&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|4|NM|LDL^LDL^L^2089-1^Cholesterol in LDL [Mass/volume] in Serum or Plasma^LN^27.1.0^2.40^LDL||116|MGDL^mg/dL^L^mg/dL^milligrams per deciliter^UCUM^27.1.0^^mg/dL|Recommended: <130; Moderate Risk: 130-159; High Risk: >160|N|||F||040.00.042.0|201402101618-0500||wjo^William Ormerod^^^^^^USER^LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO^^^^RI||LAB|201402101621-0500||||CEN^L^^^^Century Hospital&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^USA^B^^06037|2343242^Knowsalot^Phil^J.^III^Dr.^^^NIST-AA-1&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
SPM|1|^041.00003&LAB&1.3.6.1.4.1.4329.22.6.5.1.1&ISO||119364003^Serum specimen (specimen)^SCT^SERUM^Serum^L^07/31/2012^27.1.0^SERUM/SER||SST^Serum Separator Tube^HL70371^SST^Serum Separator Tube (Polymer Gel)^L^2.5.1^27.1.0^Serum Separator Tube (Polymer Gel)|82078001^Venous Blood Draw^SCT^VENIP^Venipuncture^L^07/31/2012^27.1.0^Venipuncture||||P^Patient^L^P^Patient^HL70369^27.1.0^2.5.1|5^mL&milliliter&UCUM&ml&ml&L&2.5.1&27.1.0&ml|||||201402101618-0500^201402101618-0500|201402101618-0500